Chapter 12 - THE MONEY RAFE MOVED BEFORE THE FALL
Federal investigators charged Rafe with securities violations.
He sold Aldercrest shares days before the board’s confidential decision to suspend Aurelia funding. The proceeds financed Greer’s lab. Whatever his motive, he traded while possessing nonpublic information.
Celeste had encouraged the sale in writing, calling it a lawful diversification. Then she preserved only messages making it appear Rafe acted alone.
Rafe’s attorney argued he relied on corporate counsel. Prosecutors still had evidence he knew the timing mattered.
“Did you know the trade could be improper?” Greer asked.
“I knew it was close to the line.”
“That means yes.”
“Yes.”
He had risked the law to protect her project without telling her, then accumulated resentment because she did not appreciate a sacrifice she could not see.
Rafe remembered the night he sold the shares. Greer was sleeping at the lab, and he signed the trade from their dark kitchen. He imagined telling her after the orchid succeeded. In that imagined future, she would understand everything and love him more.
He had funded not only research, but a fantasy in which eventual success removed the need for present honesty.
“You turned secrecy into a gift and punished me for not opening it,” she said.
Rafe lowered his eyes. “I did.”
He rejected a defense strategy blaming Greer’s pressure. He entered negotiations, agreed to testify about Celeste’s instructions, and accepted that cooperation might reduce but not erase consequences.
The board seized his remaining voting rights and completed Celeste’s appointment as CEO.
Her first act was to settle with regulators by sacrificing Nolan. Aldercrest claimed he acted alone, concealed toxicity data, and sabotaged the plant for personal gain.
Nolan retaliated.
He released recordings of Celeste directing him to move tissue to Switzerland and create “an event dramatic enough to trigger Greer’s override.”
The conspiracy became public.
Celeste denied the voice was hers. Independent analysis found no synthetic alteration, but her attorneys attacked the chain of custody.
Then Nolan disappeared.
His apartment contained packed boxes, an empty passport drawer, and one living Aurelia cutting under a portable growth lamp.
The cutting was genetically different from A17.
Someone had been conducting a second, secret line of research.
May you like
The portable lamp beside it contained pollen traps and hand-labeled nutrient cartridges. Nolan had cared for the modified cutting personally, outside every shared protocol. A calendar showed he visited before dawn on mornings he told Greer he was home with migraines.
Greer felt the particular betrayal of a colleague who used the language of collaboration while building a private experiment inside their work. Nolan had not only hidden bad results. He had constructed a second laboratory in the shadow of hers.
